Ahaha Cynata aren't evaluating the data here, chief. Your company failed the trial, might be time to move on from the $2.5B company that doesn't have a saleable product.
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-93
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.028(2.44%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.09 | $4.353M | 3.916M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 323225 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 42235 | 6 |
View Market Depth
| Last trade - 12.36pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |